BECK; Hilary Plake
Patent Applications and Registrations
Patent applications and USPTO patent grants for BECK; Hilary Plake.The latest application filed is for "immunoregulatory agents".
Company Profile
20.18.38
- BECK; Hilary Plake - Emerald Hills CA
- Beck; Hilary Plake - South San Francisco CA
- Beck; Hilary Plake - San Francisco CA
- Beck; Hilary Plake - San Carlos CA
- Beck; Hilary Plake - Redwood City CA
Patent Activity
| Patent | Date |
|---|---|
| Immunoregulatory Agents App 20220274926 - BECK; Hilary Plake ; et al. | 2022-09-01 |
| Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation App 20220267273 - DELMONTE; Albert J. ; et al. | 2022-08-25 |
| CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer Grant 11,407,721 - Bartberger , et al. August 9, 2 | 2022-08-09 |
| AhR modulators Grant 11,407,764 - Alam , et al. August 9, 2 | 2022-08-09 |
| DIHYDROTHIENO[3,2-b]PYRIDINE COMPOUNDS App 20220227780 - BECK; Hilary Plake ; et al. | 2022-07-21 |
| Amorphous And Crystalline Forms Of Ido Inhibitors App 20220169615 - POWERS; Jay Patrick ; et al. | 2022-06-02 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ; et al. | 2022-06-02 |
| Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation App 20220127233 - DELMONTE; Albert J. ; et al. | 2022-04-28 |
| Acetamido Derivatives As Dna Polymerase Theta Inhibitors App 20220098154 - BECK; Hilary Plake ; et al. | 2022-03-31 |
| Immunoregulatory agents Grant 11,242,319 - Beck , et al. February 8, 2 | 2022-02-08 |
| Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation Grant 11,236,048 - Delmonte , et al. February 1, 2 | 2022-02-01 |
| Amorphous and crystalline forms of IDO inhibitors Grant 11,236,049 - Powers , et al. February 1, 2 | 2022-02-01 |
| Heteroarylmethylene Derivatives As Dna Polymerase Theta Inhibitors App 20210387968 - BECK; Hilary Plake ; et al. | 2021-12-16 |
| Methods Of Culturing And/or Expanding Stem Cells And/or Lineage Committed Progenitor Cells Using Lactam Compounds App 20210254006 - ALAM; Muzaffar ; et al. | 2021-08-19 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ; et al. | 2021-06-17 |
| AMIDO COMPOUNDS AS AhR MODULATORS App 20210115016 - ALAM; Muzaffar ; et al. | 2021-04-22 |
| Compounds And Methods For The Modulation Of Ahr App 20210079001 - BECK; Hilary Plake ; et al. | 2021-03-18 |
| AhR MODULATORS App 20210002297 - ALAM; Muzaffar ; et al. | 2021-01-07 |
| AhR modulators Grant 10,815,250 - Alam , et al. October 27, 2 | 2020-10-27 |
| Chemokine Receptor Modulators And Uses Thereof App 20200239480 - Beck; Hilary Plake ; et al. | 2020-07-30 |
| Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation App 20200123109 - DELMONTE; Albert J. ; et al. | 2020-04-23 |
| Amorphous And Crystalline Forms Of Ido Inhibitors App 20200115342 - POWERS; Jay Patrick ; et al. | 2020-04-16 |
| Chemokine receptor modulators and uses thereof Grant 10,604,526 - Beck , et al. | 2020-03-31 |
| Immunoregulatory agents Grant 10,533,014 - Beck , et al. Ja | 2020-01-14 |
| AhR MODULATORS App 20190270754 - ALAM; Muzaffar ; et al. | 2019-09-05 |
| Chemokine Receptor Modulators And Uses Thereof App 20190152978 - Beck; Hilary Plake ; et al. | 2019-05-23 |
| Chemokine receptor modulators and uses thereof Grant 10,246,462 - Beck , et al. | 2019-04-02 |
| Immunoregulatory Agents App 20190092729 - BECK; Hilary Plake ; et al. | 2019-03-28 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ; et al. | 2019-02-28 |
| Immunoregulatory agents Grant 10,206,893 - Beck , et al. Feb | 2019-02-19 |
| Chemokine receptor modulators and uses thereof Grant 10,179,787 - Beck , et al. Ja | 2019-01-15 |
| Immunoregulatory Agents App 20190002472 - Beck; Hilary Plake ; et al. | 2019-01-03 |
| Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20180354918 - BARTBERGER; Michael D. ; et al. | 2018-12-13 |
| Immunoregulatory Agents App 20180325889 - BECK; Hilary Plake ; et al. | 2018-11-15 |
| Immunoregulatory agents Grant 10,106,546 - Beck , et al. October 23, 2 | 2018-10-23 |
| Immunoregulatory Agents App 20180282281 - BECK; Hilary Plake ; et al. | 2018-10-04 |
| Chemokine Receptor Modulators And Uses Thereof App 20180072743 - Beck; Hilary Plake ; et al. | 2018-03-15 |
| Chemokine Receptor Modulators And Uses Thereof App 20180072740 - Beck; Hilary Plake ; et al. | 2018-03-15 |
| Immunoregulatory Agents App 20170197973 - Beck; Hilary Plake ; et al. | 2017-07-13 |
| Immunoregulatory Agents App 20170143649 - Beck; Hilary Plake ; et al. | 2017-05-25 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ; et al. | 2017-05-25 |
| Immunoregulatory agents Grant 9,643,972 - Beck , et al. May 9, 2 | 2017-05-09 |
| Immunoregulatory agents Grant 9,598,422 - Beck , et al. March 21, 2 | 2017-03-21 |
| Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
| Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer Grant 9,376,425 - Bartberger , et al. June 28, 2 | 2016-06-28 |
| Pyrazole amide derivative Grant 9,365,522 - Beck , et al. June 14, 2 | 2016-06-14 |
| Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ; et al. | 2016-05-19 |
| Immunoregulatory Agents App 20160137653 - Beck; Hilary Plake ; et al. | 2016-05-19 |
| Immunoregulatory Agents App 20160137652 - Beck; Hilary Plake ; et al. | 2016-05-19 |
| Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
| Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160002185 - BARTBERGER; Michael D. ; et al. | 2016-01-07 |
| Pyrazole Amide Derivative App 20150266824 - Beck; Hilary Plake ; et al. | 2015-09-24 |
| Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ; et al. | 2014-10-23 |
| Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20140235629 - Bartberger; Michael D. ; et al. | 2014-08-21 |
| Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140011796 - BARTBERGER; Michael David ; et al. | 2014-01-09 |
| Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20110319378 - BARTBERGER; Michael David ; et al. | 2011-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 